4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MannKind Corporation (MNKD) operates in the Biotechnology industry and is headquartered in Danbury, United States with about 591 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, MNKD reported $349M in revenue and $6M in net income.
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.
Interactive charts & full statements → Open the MNKD valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $349M | $286M | $199M | $100M | — |
| Gross Profit | $261M | $209M | $136M | $42M | — |
| Operating Income (EBIT) | $46M | $69M | $11M | ($69M) | — |
| Net Income | $6M | $28M | ($12M) | ($87M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $90M | $112M | $82M | $76M | $78M | — |
| Gross Profit | $73M | $82M | $62M | $56M | $61M | — |
| Operating Income (EBIT) | ($3M) | ($8M) | $19M | $11M | $25M | — |
| Net Income | ($17M) | ($16M) | $8M | $1M | $13M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $792M | $394M | $475M | $295M | — |
| Total Liabilities | $843M | $473M | $721M | $546M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MNKD viewer.
About TickerBase · Data methodology & sources